Mingkai Lin, MD, PHD
2013.01-now Department of Glaucoma, Zhongshan Ophthalmic Center, Sun Yat
-sen University, Chief Doctor.
2003.12-2012.12 Department of Glaucoma, Zhongshan Ophthalmic Center, Sun Yat
-sen University, Associate Chief Doctor.
1998.12-2003.12 Department of Glaucoma, Zhongshan Ophthalmic Center, Sun Yat
-sen University, Doctor in Charge.
1990.07-1998.12 Department of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat
-sen University, Assistant.
2009.07-2011.01 University of Oklahoma Health Science Center, Oklahoma City, the USA. Visiting Scholar.
2002.11-2003.10 School of Optometry, UC Berkeley, USA. Post-doctor. The Scripps Research Institute, San Diego, USA. Post-doctor.
1998.09-2001.06 Zhongshan Ophthalmic Center, Sun Yat-sen University, Ph.D student.
1995.09-1998.08 Zhongshan Ophthalmic Center, Sun Yat-sen University, Master degree
1984.09-1990.06 Department of Medicine, Sun Yat-sen University, Medical training.
Committed to glaucoma optic nerve protection, and anti-scarring after glaucoma surgery. Mainly study the role of hypoxia inducible factor-1 (HIF-1) factor and its pathway in glaucoma.
One-month IOP in mitomycin C-augmented trabeculectomy can predict long-term IOP control in chronic primary angle-closure glaucoma.
Investigation of Corneal Astigmatism in Chinese Patients With Primary Angle Closure Disease.
Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization.
Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.